Biomerica (BMRA) Consolidated Net Income (2010 - 2026)
Biomerica (BMRA) posted Consolidated Net Income of -$1.3 million for Q1 2026, up 0.61% sequentially from -$1.3 million in Q4 2025, and down 12.81% YoY from -$1.5 million in Q1 2025.
Biomerica (BMRA) Consolidated Net Income (2010 - 2026) Analysis & Trends
Biomerica has reported Consolidated Net Income for 17 years, with the latest figure at -$1.3 million in Q1 2026.
- Quarterly Consolidated Net Income fell 12.81% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$4.2 million (up 10.47% YoY) and the FY2025 annual result came in at -$5.0 million, up 14.12% from the prior year.
- Consolidated Net Income grew to -$1.3 million in Q1 2026 per BMRA's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $2000.0 in Q3 2025 and troughed at -$2.3 million in Q2 2023.
- A 5-year average of -$1.3 million and a median of -$1.3 million in 2025 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2023 and 2025: Consolidated Net Income tumbled 1483.98% in 2023, then soared 100.15% in 2025.
- Over 5 years, Consolidated Net Income stood at -$1.6 million in 2022, then climbed by 7.32% to -$1.5 million in 2023, then jumped by 36.96% to -$950000.0 in 2024, then plunged by 38.95% to -$1.3 million in 2025, then advanced by 0.61% to -$1.3 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$1.3 million, -$1.3 million, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Biomerica | 4.58 Mn | 3.24 Mn | -44,000.00 | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.31 Mn |
| Nov 30, 2025 | -1.32 Mn |
| Aug 31, 2025 | 2,000.00 |
| May 31, 2025 | -1.54 Mn |
| Feb 28, 2025 | -1.16 Mn |
| Nov 30, 2024 | -950,000.00 |
| Aug 31, 2024 | -1.32 Mn |
| May 31, 2024 | -1.23 Mn |
| Feb 29, 2024 | -1.92 Mn |
| Nov 30, 2023 | -1.51 Mn |
| Aug 31, 2023 | -1.13 Mn |
| May 31, 2023 | -2.32 Mn |
| Feb 28, 2023 | -1.65 Mn |
| Nov 30, 2022 | -1.63 Mn |
| Aug 31, 2022 | -2.07 Mn |
| May 31, 2022 | -1.76 Mn |
| Feb 28, 2022 | -104,168.00 |
| Nov 30, 2021 | -1.13 Mn |
| Aug 31, 2021 | -1.54 Mn |
| May 31, 2021 | -3.26 Mn |